Specifically, the guidelines recommend that individuals with elevated B-type natriuretic peptide (BNP), N-terminal pro-B-type natriuretic peptide (NT-proBNP), or persistently elevated levels of high-sensitivity cardiac troponins in the setting of exposure to cardiotoxic agents be classified as Stage B HF or pre-HF. Here, NPPB is linked to hydrops fetalis.